OTCMKTS:MSLP MusclePharm (MSLP) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC Filings About MusclePharm Stock (OTCMKTS:MSLP) Get MusclePharm alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume26,442 shsMarket Capitalization$7 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview MusclePharm Corporation is a sports nutrition company known for developing, marketing and distributing nutritional supplements for athletes, fitness enthusiasts and active consumers. Its product portfolio has included protein powders, ready-to-drink beverages, protein bars, pre-workout formulas, branched-chain amino acids, creatine and other performance- and recovery-oriented supplements. Founded in 2006, the company built its brand through products sold under the MusclePharm name and related product lines. Its offerings have historically been distributed through specialty nutrition retailers, gyms, e-commerce platforms and other retail channels, serving consumers in the United States and select international markets. MusclePharm has experienced significant corporate and financial challenges, including a Chapter 11 bankruptcy filing in 2020. Because the company's ownership, operations and leadership have changed over time, current management information and the scope of its ongoing business are not clearly established from consistently reliable public sources.AI Generated. May Contain Errors. Read More Receive MSLP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MSLP Stock News HeadlinesMusclePharm and City Football Group Announce Multi-Year PartnershipJune 25, 2026 | finance.yahoo.comTry This Trick to Lose Weight and Gain Lean Muscle at the Same TimeOctober 28, 2024 | cnet.comElon’s AI Phone is comingRumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.September 26 at 1:00 AM | Stansberry Research (Ad)The 5 best muscle rubs of 2024February 11, 2024 | businessinsider.com7 Healthy Habits to Decrease the Risk of Breast CancerNovember 2, 2023 | msn.comFitLife Brands swoops in for bankrupt MusclePharm assetsOctober 2, 2023 | msn.comUS Bankruptcy Court Approves FitLife's $18.5M Acquisition Of MusclePharmSeptember 28, 2023 | msn.comFitLife Brands to Acquire Substantially All of the Assets of MusclePharm CorporationSeptember 27, 2023 | benzinga.comSee More Headlines MSLP Stock Analysis - Frequently Asked Questions How were MusclePharm's earnings last quarter? MusclePharm Co. (OTCMKTS:MSLP) issued its quarterly earnings data on Monday, August, 10th. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.19) by $0.32. The firm earned $50.48 million during the quarter, compared to analysts' expectations of $55 million. How do I buy shares of MusclePharm? Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MusclePharm own? Based on aggregate information from My MarketBeat watchlists, some other companies that MusclePharm investors own include Altimmune (ALT), Avino Silver & Gold Mines (ASM), BellRing Brands (BRBR), Dalradian Resources (DALR), EVRAZ (EVRZF), Humacyte (HUMA) and Company Calendar Last Earnings8/10/2015Today9/26/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:MSLP CIK1415684 Webwww.musclepharm.com Phone(800) 292-3909FaxN/AEmployees20Year Founded2008Profitability EPS (Trailing Twelve Months)($0.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.87 million Net Margins-38.51% Pretax Margin-38.52% Return on EquityN/A Return on Assets-169.56% Debt Debt-to-Equity RatioN/A Current Ratio0.25 Quick Ratio0.23 Sales & Book Value Annual Sales$50.04 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.94) per share Price / BookN/AMiscellaneous Outstanding Shares33,390,000Free Float13,121,000Market Cap$7 thousand OptionableNot Optionable Beta-0.07 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:MSLP) was last updated on 9/26/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...Stansberry Research | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredMake this "Money Move" Before Midterms November 3rdAddison Wiggin has interviewed Warren Buffett, questioned two former Treasury Secretaries, and warned of the 2...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MusclePharm Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share MusclePharm With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MSLP Stock Alerts